IFNG and neoplasm: Although baseline IDO expression was undetectable in LLCs, IDO was induced in LLCs treated with recombinant mouse IFN-γ (Supplementary Figure S2C), suggesting that cytokines and other factors in the TME can induce IDO in tumor cells transplanted into IDO-deficient mice.